86 related articles for article (PubMed ID: 12215240)
1. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
[TBL] [Abstract][Full Text] [Related]
3. Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review.
Rios-Diaz AJ; Lam J; Ramos MS; Moscoso AV; Vaughn P; Zogg CK; Caterson EJ
PLoS One; 2016; 11(2):e0148304. PubMed ID: 26862894
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
Stanciole AE; Ortegón M; Chisholm D; Lauer JA
BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of surgery in low- and middle-income countries: a systematic review.
Grimes CE; Henry JA; Maraka J; Mkandawire NC; Cotton M
World J Surg; 2014 Jan; 38(1):252-63. PubMed ID: 24101020
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis.
Tolla MT; Norheim OF; Memirie ST; Abdisa SG; Ababulgu A; Jerene D; Bertram M; Strand K; Verguet S; Johansson KA
Cost Eff Resour Alloc; 2016; 14():10. PubMed ID: 27524939
[TBL] [Abstract][Full Text] [Related]
7. Reducing non-communicable diseases among Palestinian populations in Gaza: A participatory comparative and cost-effectiveness modeling assessment.
Basu S; Yudkin JS; Jawad M; Ghattas H; Hamad BA; Jamaluddine Z; Safadi G; Ragi ME; Ahmad RES; Vamos EP; Millett C
PLOS Glob Public Health; 2024; 4(5):e0003168. PubMed ID: 38696423
[TBL] [Abstract][Full Text] [Related]
8. Simulated impacts and potential cost effectiveness of Communities Putting Prevention to Work: Tobacco control interventions in 21 U.S. communities, 2010-2020.
Honeycutt A; Bradley C; Khavjou O; Yarnoff B; Soler R; Orenstein D
Prev Med; 2019 Mar; 120():100-106. PubMed ID: 30659909
[TBL] [Abstract][Full Text] [Related]
9. Modeling the cost effectiveness of injury interventions in lower and middle income countries: opportunities and challenges.
Bishai DM; Hyder AA
Cost Eff Resour Alloc; 2006 Jan; 4():2. PubMed ID: 16423285
[TBL] [Abstract][Full Text] [Related]
10. Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision.
Hailu A; Eregata GT; Yigezu A; Bertram MY; Johansson KA; Norheim OF
Cost Eff Resour Alloc; 2021 Sep; 19(1):58. PubMed ID: 34521437
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
Baltussen R; Smith A
BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation.
Smith TT; Rupprecht LE; Sved AF; Donny EC
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3953-3964. PubMed ID: 27627909
[TBL] [Abstract][Full Text] [Related]
13. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization.
Chisholm D
World Psychiatry; 2005 Feb; 4(1):37-44. PubMed ID: 16633504
[TBL] [Abstract][Full Text] [Related]
14. Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina.
Rubinstein A; García Martí S; Souto A; Ferrante D; Augustovski F
Cost Eff Resour Alloc; 2009 May; 7():10. PubMed ID: 19419570
[TBL] [Abstract][Full Text] [Related]
15. Cost Effectiveness of Environmental Lead Risk Mitigation in Low- and Middle-Income Countries.
Ericson B; Caravanos J; Depratt C; Santos C; Cabral MG; Fuller R; Taylor MP
Geohealth; 2018 Feb; 2(2):87-101. PubMed ID: 32159011
[TBL] [Abstract][Full Text] [Related]
16. National Trends in Sales and Price for Commercial Tobacco and Nicotine Products, 2018-2022.
Ganz O; LaVake M; Hrywna M; King Jensen JL; Delnevo CD
JAMA Netw Open; 2024 Mar; 7(3):e241384. PubMed ID: 38451527
[TBL] [Abstract][Full Text] [Related]
17. Tobacco control since the 1964 Surgeon General's Report: reflecting back and looking forward.
Mulshine JL; Healton C
Oncology (Williston Park); 2014 Mar; 28(3):180, 182-3, 210. PubMed ID: 24855724
[No Abstract] [Full Text] [Related]
18. Real-world, anti-tobacco environmental impact upon price-induced smoking reduction among urban Chinese men: Evidence from China's 2015 cigarette tax increase.
Pei T; Barnett P; Yang T; Rockett IRH; Zhang W
Tob Induc Dis; 2023; 21():124. PubMed ID: 37808587
[TBL] [Abstract][Full Text] [Related]
19. Does health economics research align with the disease burden in the Middle East and North Africa region? A systematic review of economic evaluation studies on public health interventions.
Nagi MA; Rezq MAA; Sangroongruangsri S; Thavorncharoensap M; Dewi PEN
Glob Health Res Policy; 2022 Jul; 7(1):25. PubMed ID: 35879742
[TBL] [Abstract][Full Text] [Related]
20. Simulating the bounds of plausibility: Estimating the impact of high-risk versus population-based approaches to prevent firearm injury.
Keyes KM; Hamilton A; Tracy M; Kagawa RMC; Pear VA; Fink D; Branas CC; Cerdá M
PLoS One; 2022; 17(6):e0269372. PubMed ID: 35653403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
